Cholangiocarcinoma

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Biliary Cell-derived Organoids From Bile of PSC and Non-PSC

Recruiting
  • Primary Sclerosing Cholangitis
  • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 9, 2023

    Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

    Active, not recruiting
    • Cholangiocarcinoma
    • +6 more
    • Laboratory Biomarker Analysis
    • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
    • Scottsdale, Arizona
    • +1 more
    Jan 4, 2023

    Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation Trial in United States (TT-00420)

    Recruiting
    • Cholangiocarcinoma
    • +4 more
    • Anchorage, Alaska
    • +16 more
    Jan 3, 2023

    Prospective Evaluation of Biliary Tissue Sampling With ERCP

    Enrolling by invitation
    • Cholangiopancreatography, Endoscopic Retrograde
    • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Nov 7, 2022

      Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

      Completed
      • Biliary Tract Cancer
      • +2 more
      • Scottsdale, Arizona
      • +32 more
      Oct 21, 2022

      Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

      Recruiting
      • Acinar Cell Carcinoma
      • +93 more
      • Biospecimen Collection
      • +2 more
      • Birmingham, Alabama
      • +998 more
      Aug 23, 2022

      Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

      Recruiting
      • Ovarian Cancer
      • +68 more
      • Phoenix, Arizona
      • +8 more
      Aug 18, 2022

      Cholangiocarcinoma Trial in Worldwide (Pemigatinib)

      Completed
      • Cholangiocarcinoma
      • Anchorage, Alaska
      • +119 more
      Apr 4, 2022

      Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)

      Active, not recruiting
      • Cholangiocarcinoma
      • Fimaporfin and Gemcitabine
      • Gemcitabine/Cisplatin chemotherapy
      • Duarte, California
      • +49 more
      Mar 4, 2022

      Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester

      Recruiting
      • Primary Sclerosing Cholangitis
      • +3 more
        • Rochester, Minnesota
          Mayo Clinic
        Feb 22, 2022

        Cholangiocarcinoma Trial in Korea, Republic of, Taiwan, United States (CX-4945, Cisplatin, Gemcitabine)

        Completed
        • Cholangiocarcinoma
        • Scottsdale, Arizona
        • +15 more
        Oct 20, 2021

        Cholangiocarcinoma Trial in Austria, United States (Nab-Paclitaxel and Gemcitabine)

        Completed
        • Cholangiocarcinoma
        • Nab-Paclitaxel and Gemcitabine
        • Denver, Colorado
        • +24 more
        Sep 5, 2018

        Primary Sclerosing Cholangitis, Trisomy 7, Cholangiocarcinoma Trial in Rochester (Erlotinib (Tarceva))

        Completed
        • Primary Sclerosing Cholangitis
        • +3 more
        • Erlotinib (Tarceva)
        • Rochester, Minnesota
          Mayo Clinic
        Jan 9, 2014